Bel Fuse Inc. (NASDAQ: BELFB). Extremely significant negative changes in investment behavior have recently occurred: the stock’s recent price decline challenged its longer term uptrend, and negative upside/downside volume developed. Important negative changes in Bel […]
Lee Enterprises Inc (NASDAQ: LEE) stock enjoyed a major increase of 13.9% on 3/20/25. The shares closed at $9.99. Moreover, this advance was accompanied by exceptionally high trading volume at 567% of normal. Relative to […]
Lands’ End Inc (NASDAQ: LE) has reported earnings for its fourth fiscal quarter (ending January 31) of $0.60 versus a loss $-0.27 for the same period a year ago — a decline of -322%. E.P.S. […]
First Guaranty Bancshares Inc (NASDAQ: FGBI) stock enjoyed a major increase of 20.8% on 3/20/25. The shares closed at $8.53. Trading volume in this advance was normal. The stock has performed in line with the […]
Gogo Inc (NASDAQ: GOGO) stock closed at $7.70 on 3/19/25 after a major increase of 11.1%. Moreover, exceptionally high trading volume at 356% of normal accompanied the advance. The stock has been weak relative to […]
Capricor Therapeutics Inc (NASDAQ: CAPR) has reported E.P.S. of $-0.16 for its fourth fiscal quarter (ending December 31) versus $-0.02 for the same period a year ago — an increase of 700%. For the latest […]
Adverum Biotechnologies Inc (NASDAQ: ADVM) stock enjoyed a major increase of 10.4% on 3/19/25. The shares closed at $5.41. Trading volume in this advance was normal. The stock has risen 21.0% during the last week […]
ADMA Biologics Inc (NASDAQ: ADMA) stock enjoyed a major increase of 10.2% on 3/19/25. The shares closed at $20.61. Moreover, trading volume in this advance was exceptionally high at 214% of normal. The stock has […]
Xunlei Ltd (NASDAQ: XNET) stock closed at $5.11 on 3/19/25 after a major increase of 14.1%. This advance was accompanied by normal trading volume. Relative to the market the stock has been exceptionally strong over […]
Five Below Inc (NASDAQ: FIVE) has reported earnings for its fourth fiscal quarter (ending January 31) of $3.41 versus $3.66 for the same period a year ago — a decline of -7%. For the latest […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research